Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideALNYAlnylam Pharmaceuticals
FinDog View：Neutral
MRKMerck & Co.
FinDog View：Neutral
| Metric | ALNY | MRK |
|---|
| Close | 227.02 | 145.45 |
| Market Cap | $31.1B | $359B |
| 1M | −8.71% | +1.06% |
| P/E (TTM) | 38.5 | 113.2 |
| Forward P/E | 28.0 | 19.6 |
| P/E 5-Yr Percentile | — | 80 |
| P/S | 6.5 | 5.4 |
| P/B | 23.0 | 8.6 |
| Dividend Yield | — | 2.87% |
| Latest Quarter Revenue | $1.3B | $16.6B |
| Revenue YoY | +66.9% | +5.1% |
| Gross Margin | 76.9% | 73.5% |
| Latest Quarter EPS | 1.21 | -0.54 |
| Avg Post-Earnings Move | ±1.7% | ±1.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | — | 3.48% |
| 90-Day Net Insider Buying | −$0.40M | −$30.0M |
ALNY · Revenue, Last 8 Quarters ($B)
MRK · Revenue, Last 8 Quarters ($B)
